CUBICIN RF (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the CUBICIN RF drug offered from Merck Sharp & Dohme Corp.. This Lipopeptide Antibacterial [EPC],Lipopeptides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
NON-PROPRIETARY NAME: | Daptomycin |
SUBSTANCE NAME: | DAPTOMYCIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Lipopeptide Antibacterial [EPC],Lipopeptides [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-09-13 |
END MARKETING DATE: | 0000-00-00 |
CUBICIN RF HUMAN PRESCRIPTION DRUG Details:
Item Description | CUBICIN RF from Merck Sharp & Dohme Corp. |
LABELER NAME: | Merck Sharp & Dohme Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/10mL) |
START MARKETING DATE: | 2016-09-13 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67919-012_a4b88d67-07ab-4bab-9612-3d5fcdbec518 |
PRODUCT NDC: | 67919-012 |
APPLICATION NUMBER: | NDA021572 |
Other DAPTOMYCIN Pharmaceutical Manufacturers / Labelers: